ArticleFrontiers in pharmacology2025
Characterization and anti-inflammatory studies of supramolecular assemblies of chlorogenic acids with metal ions.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- AI-driven drug-target interaction prediction: current progress, challenges, and future roadmap for precision medicine.Journal of computer-aided molecular design · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Self-assembled natural small molecules are believed to have numerous potential applications, particularly in the material and pharmaceutical industries, as self-assembly increases the anti-inflammatory, antitumor, antiviral, and other biological activities. In this study, we synthesized more potent potential anti-inflammatory agents by combining chlorogenic acids with metals (iron and copper). Methods: Supramolecular assemblies were synthesized by combining chlorogenic acids with iron and copper. The synthesis conditions were optimized using mass spectrometry. The resulting complexes were comprehensively characterized by ultraviolet-visible spectroscopy, Fourier-transform infrared spectroscopy, and mass spectrometry to confirm their formation and stoichiometry. The anti-inflammatory activity was evaluated in vitro using lipopolysaccharide-induced RAW264.7 macrophages. The production of inflammatory mediators (NO, IL-6, IL-1β, TNF-α) was measured. Mechanistic studies were conducted to assess the effects on the NF-κB signaling pathway and the expression of downstream proteins iNOS and COX-2. Results: Characterization data confirmed the successful formation of chlorogenic acid-metal supramolecules, primarily in a 1:1 stoichiometry. These metal-based complexes exhibited significantly enhanced anti-inflammatory effects compared to the parent chlorogenic acid molecules. Discussion: The findings confirm that complexation with metals (iron and copper) successfully enhances the anti-inflammatory efficacy of chlorogenic acids. The primary mechanism involves the inhibition of the NF-κB pathway. This study provides a novel and efficient strategy for augmenting the bioactivities of natural products and highlights the considerable potential of chlorogenic acid-metal supramolecular assemblies as a promising new class of anti-inflammatory agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.